Showing results 1 to 4 of 4
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Effects of SB9200 (Inarigivir) therapy on immune responses in patients with chronic hepatitis B Proceeding/Conference:Journal of Hepatology | 2018 | ||
Inarigivir: a novel RIG-I agonist for chronic hepatitis B Proceeding/Conference:Hepatology International | 2018 | ||
Novel anti-viral activity of SB 9200, a RIGI agonist; results from Cohort 1 of the ACHIEVE trial Proceeding/Conference:Hepatology | 2017 | ||
Predicting HBsAg clearance responses during ARC-520 RNA interference (RNAi) therapy based on HBsAg epitope profile analysis Proceeding/Conference:Journal of Hepatology | 2016 |